Allergy Thera【AGY】銘柄情報

Allergy Thera (AGY) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

6.50

( -1.52% )

買値

6.00

売値

7.00

出来高

51,314

平均取引量 (3 か月)

251,904p

財務取引量

3,429p

6.30 日の範囲 6.96

6.07 52 週間の範囲 12.15

時価総額

411.614M

企業価値

448.546M

前日終値

6.60

始値

6.50

時刻

27000

6.7

(UT)

最終取引時間

VWAP

6.6831

歳入

57.29M

純利益

-48.18M

発行済株式数

6,332,529,550

浮動株比率 (%)

11.42%

機関投資家保有比率 (%)

95.27%

配当利回り

PER

-7.07

株価売上高倍率 (PSR)

7.54

1 株当たり利益 (EPS)

-0.01

ベータ

0.87

Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies, ... Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies, and offers treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as well as diagnostics products. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Synbiotics, and Acarovac Plus. It also develops Grass MATA MPL, a subcutaneous allergen-specific immunotherapy candidate that aims to address the cause of symptoms of allergic rhinoconjunctivitis due to grass pollen; and VLP Peanut, a short-course peanut allergy vaccine. Allergy Therapeutics plc was founded in 1998 and is headquartered in Worthing, the United Kingdom. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.allergytherapeutics.com

本社

Worthing, United Kingdom

設立

1998

Allergy Thera is listed in the Healthcare sector of the ロンドン証券取引所 with ticker AGY. The last closing price for Allergy Thera was 6.60p. Over the last year, Allergy Thera shares have traded in a share price range of 6.07p to 12.15p.

Allergy Thera currently has 6,332,529,550 shares in issue. The market capitalisation of Allergy Thera is £411.61 million. Allergy Thera has a price to earnings ratio (PE ratio) of -7.07.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.25	-3.7037037037	6.75	7.28	6.07	220798	6.36384783	DE
4	-1.5	-18.75	8	8.91	6.07	215777	7.10109745	DE
12	-4	-38.0952380952	10.5	11.425	6.07	229766	8.647052	DE
26	-4.25	-39.5348837209	10.75	12.15	6.07	253705	9.89424482	DE
52	-1.125	-14.7540983607	7.625	12.15	6.07	292924	9.3189205	DE
156	5.05	348.275862069	1.45	12.15	1.275	538251	4.6804138	DE
260	-19	-74.5098039216	25.5	40	0.85	434281	7.22001135	DE